INTEGRA Biosciences drives down transport emissions with European production facility

INTEGRA Biosciences has completed construction of its new campus and pipette tip manufacturing plant at its headquarters in Zizers, Switzerland. The manufacturing facility will help the company drastically reduce its transport emissions, which is in line with its long-term sustainability goals.

The transport of raw materials and products accounted for 44 percent of INTEGRA’s CO2 emissions in 2022. Around 75 percent of this was attributed to the transport of GRIPTIPS® pipette tips from the USA manufacturing facility to subsidiaries and distributors worldwide. Construction of a second pipette tip production facility in Zizers was completed in December 2023, and will help to eliminate the need to ship pipette tips from the USA to European customers, reducing transport emissions by an estimated 26 percent.

All of the additional buildings at the expanded Zizers campus have been designed with sustainability in mind. The new buildings have a range of eco-friendly features, with low energy consumption and a 3000 m2 rooftop photovoltaic system to generate electricity.

Heat generated by the pipette tip molding facility and fossil fuel-free heat pumps will also be used to heat the campus. In addition, 1625 m2 of roof space will be seeded with 50 species of native wildflowers to support local biodiversity.

“We are dedicated to a proactive and company-wide approach to sustainability. Manufacturing GRIPTIPS in Europe is a huge step in reducing our carbon footprint and achieving our corporate emissions reduction targets.”

Ursula Leuthold, Sustainability Coordinator for INTEGRA Biosciences

Visit the INTEGRA Biosciences website to learn more.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2024, March 21). INTEGRA Biosciences drives down transport emissions with European production facility. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/20240321/INTEGRA-Biosciences-drives-down-transport-emissions-with-European-production-facility.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA Biosciences drives down transport emissions with European production facility". News-Medical. 24 April 2024. <https://www.news-medical.net/news/20240321/INTEGRA-Biosciences-drives-down-transport-emissions-with-European-production-facility.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA Biosciences drives down transport emissions with European production facility". News-Medical. https://www.news-medical.net/news/20240321/INTEGRA-Biosciences-drives-down-transport-emissions-with-European-production-facility.aspx. (accessed April 24, 2024).

  • Harvard

    INTEGRA Biosciences. 2024. INTEGRA Biosciences drives down transport emissions with European production facility. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/20240321/INTEGRA-Biosciences-drives-down-transport-emissions-with-European-production-facility.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Developing a novel norovirus vaccine candidate with INTEGRA pipettes